Stockholm - Free Realtime Quote SEK
Prostatype Genomics AB (publ) (PROGEN.ST)
1.7600
-0.0200
(-1.12%)
As of 9:00:02 AM GMT+2. Market Open.
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Revenue
199
199
1,356
683
10.0010
Cost of Revenue
-1,719
-1,719
-2,372
--
-2,499.6410
Gross Profit
1,918
1,918
3,728
683
2,509.6420
Operating Expense
42,772
42,772
42,975
29,372
18,057.9070
Operating Income
-40,854
-40,854
-39,247
-28,689
-15,548.2650
Net Non Operating Interest Income Expense
-1,634
-1,634
-1,536
-397
-81.4930
Pretax Income
-41,051
-41,051
-41,435
-29,087
-15,629.7580
Net Income Common Stockholders
-41,051
-41,051
-41,435
-29,087
-15,629.7580
Diluted NI Available to Com Stockholders
-41,051
-41,051
-41,435
-29,087
-15,629.7580
Basic EPS
-93.94
-2.87k
-162.91k
-596.52
-104.38
Diluted EPS
-93.94
-2.87k
-162.91k
-596.52
-104.38
Basic Average Shares
787.1380
3,003.4740
172.0690
38.7540
149.7400
Diluted Average Shares
787.1380
3,003.4740
172.0690
38.7540
149.7400
Total Operating Income as Reported
-40,853
-40,853
-39,247
-28,689
-15,548.2650
Total Expenses
41,053
41,053
40,603
29,372
15,558.2660
Net Income from Continuing & Discontinued Operation
-41,051
-41,051
-41,435
-29,087
-15,629.7580
Normalized Income
-41,051
-41,051
-41,435
-29,087
-15,629.7580
Interest Income
43
43
4
--
--
Interest Expense
1,677
1,677
1,540
397
81.4930
Net Interest Income
-1,634
-1,634
-1,536
-397
-81.4930
EBIT
-39,374
-39,374
-39,895
-28,690
-15,548.2650
EBITDA
-37,395
-37,395
-38,020
-26,786
-15,459.7820
Reconciled Cost of Revenue
-1,719
-1,719
-2,372
--
-2,499.6410
Reconciled Depreciation
1,979
1,979
1,875
1,904
88.4830
Net Income from Continuing Operation Net Minority Interest
-41,051
-41,051
-41,435
-29,087
-15,629.7580
Normalized EBITDA
-37,395
-37,395
-38,020
-26,786
-15,459.7820
12/31/2021 - 11/3/2020
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
Upgrade